Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
China Health Group ( (HK:0673) ) has provided an announcement.
China Health Group Limited has announced a supplemental update to its annual report for the financial year ending March 31, 2025. The update highlights an impairment loss of approximately HK$11.7 million related to expected credit losses on loan and interest receivables. The company has taken legal action to recover a loan from Shuangluan Hospital, with ongoing litigation at the Chengde Court and discussions with the Shuangluan Government for possible repayment plans. The outcome of these actions could significantly impact the company’s financial recovery efforts and its stakeholders.
The most recent analyst rating on (HK:0673) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Health Group stock, see the HK:0673 Stock Forecast page.
More about China Health Group
China Health Group Limited is a company incorporated in Bermuda with limited liability, operating in Hong Kong under the name CHG HS Limited. The company is involved in the healthcare industry, focusing on providing health-related services and products.
Average Trading Volume: 831,133
Technical Sentiment Signal: Buy
Current Market Cap: HK$830.3M
Find detailed analytics on 0673 stock on TipRanks’ Stock Analysis page.